Advertisement

Topics

Search Results for "Galderma Company Rpofile"

18:02 EDT 25th May 2017 | BioPortfolio

Matching Channels

Medtronic

With annual sales reaching $15 billion in 2010, Medtronic is the 4th largest medical devices company in the world (based on annual sales). The device portfolio of Medtronic is broad; covering card...

The Top 100 Drugs

The pharmaceutical industry is massive, both in range of products and in financial values. These are the top 200 drugs (ranked in descending order according to total sales in 20010, $), and the co...

MediciGlobal is a specialty patient recruitment-retention organization serving the clinical trials industry

MediciGlobal is a specialty patient recruitment-retention organization serving the clinical trials industry. For more than two decades, the company has led the industry in developing innovative p...

Datamonitor - aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapidly evolving marketplace

The Datamonitor Group aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapi...

Rivaroxaban

Rivaroxaban is the most broadly indicated novel oral anticoagulant and is marketed under the brand name Xarelto®. To date, Xarelto has been approved for use in the following indications across t...

Matching News

Market Research Proves Success of Galderma’s Harmony Programme for Aesthetic Practice

For additional information:GaldermaMårten Forrest, +46 768 98 1106Head of PR & CommunicationAesthetic & Corrective Businessmarten.forrest@galderma.com Read more...

Juvly Aesthetics Now Offering New Restylane Product

Galderma, the manufacturer of Dysport, Sculptra, and the Restylane Family of Fillers saw the need for a dermal filler to cater to those who have expressed interest in fillers, but demand a natural loo...

Bioventus, Galderma deal

Galderma SA Strategic SWOT Analysis Review [Updated: 28032017] Prices from USD $125

Galderma SA Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT anal...

Galderma Laboratories Presents Results From Phase IV Clinical Studies Of Restylane Refyne And Restylane Defyne At The

c   Life Sciences Jobs   ...

Galderma Laboratories Release: Differin Gel Acne Treatment Partners With Actress To End Adult Acne Frustrations For Millions Of Sufferers

  Life Sciences Jobs   ...

Galderma Laboratories LP Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250

SummaryGalderma Laboratories LPGalderma, a subsidiary of Galderma SA is a dermatology product provider that offers skincare products. The company research, develops, and markets dermatology products. ...

Differin Gel launch gets boost with Ashley Benson partnership

David SalazarAhead of its national launch of Differin Gel, a prescription-strength OTC retinoid acne treatment, Galderma has announced its partnership with “Pretty Little Liars” actress As...

Matching PubMed Articles

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement